Ishikawa, Japan

Satoru Kyo

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Kanazawa, JP (2011)
  • Ishikawa, JP (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Satoru Kyo: Innovator in Cancer Therapy

Introduction

Satoru Kyo, an accomplished inventor based in Ishikawa, Japan, has made significant contributions to the field of cancer research. With two patented innovations to his name, he is at the forefront of developing groundbreaking therapies aimed at improving cancer detection and treatment.

Latest Patents

Kyo's latest patents reflect his commitment to finding advanced solutions in oncology. The first patent revolves around an oncolytic virus that selectively replicates in tumor cells. This innovation utilizes a virus engineered with a gene sequence featuring a telomerase promoter and E1 gene (specifically, E1A, IRES sequence, and E1B gene). The virus demonstrates an efficient anticancer effect by targeting cancer cells for replication.

The second patent pertains to Telomelysin/GFP-expressing recombinant virus, a reagent designed for cancer cell detection and diagnosis. This invention integrates a replication cassette containing a human telomerase promoter, E1A gene, IRES sequence, and E1B gene in the viral genome's E1 region, along with a labeling cassette for the detection of cancer cells through a labeling protein.

Career Highlights

Satoru Kyo works for Oncolys Biopharma, a progressive company focused on harnessing innovative biopharmaceutical solutions. His work contributes to advancing therapies aimed at enhancing cancer treatment protocols and improving patient outcomes.

Collaborations

Kyo has collaborated with notable colleagues in the industry, including Toshiyoshi Fujiwara and Noriaki Tanaka. These partnerships underscore the collaborative spirit of research and innovation, crucial for breakthroughs in oncology.

Conclusion

Satoru Kyo stands out as a visionary inventor dedicated to transforming cancer therapies. His patents not only highlight his innovative thinking but also pave the way for future advancements in the fight against cancer. Through his work at Oncolys Biopharma and collaborations with fellow researchers, Kyo continues to make strides toward improving cancer diagnosis and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…